At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets.

Jurj, A; Qian, D; Calin, G A; Litchfield, K

Jurj, A; Qian, D; Calin, G A; Litchfield, K.

Afiliación

Jurj A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; The Research Center for Functional Genomics, Biomedicine and Translational Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj Napoca, Romania.
Qian D; Department of Oncology, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Calin GA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: gcalin@mdanderson.org.
Litchfield K; Department of Oncology, University College London Cancer Institute, Paul O'Gorman Building, London, UK. Electronic address: Kevin.Litchfield@crick.ac.uk.

Ann Oncol ; 33(12): 1214-1216, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36456103

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Rumanía Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google